The Mumbai headquartered company reported 47.3% year-on-year growth in net profit at Rs 52.6 crore while revenue from operations rose by 40% to Rs 246.3 crore for the September quarter. Loan disbursement increased by 25% to Rs 701 crore.
SBFC Finance stands out as a rapidly expanding non-banking financial company (NBFC) with robust earnings growth and stable asset quality, said Anubhuti Mishra, Equity Research Analyst at Swastika Investmart.
Led by the robust institutional response, the initial public offer (IPO) of SBFC Finance was subscribed by a massive 70.16 times at close. Monday was the last day of bidding for investors.
SBFC Finance is expected to announce its share allotment status on August 10.The shares of SBFC Finance were subscribed by 70.16 times overall.The shares are
If you had subscribed to SBFC Finance IPO, you can check the status of your application online either via the BSE website or through the website of the registrar.
Investors bid for 150.22 crore equity shares against an offer size of 13.35 crore, subscription data available with the exchanges shows. The stock will list on August 16
The issue of SBFC Finance comprises fresh equity issue of Rs 600 crore and an offer for sale (OFS) of Rs 425 crore, while Concord Biotech is completely an OFS of 2.09 crore equity shares up, aggregating up to Rs 1,551 crore.
Institutional and non-institutional investors led the bidding as both categories were subscribed 21 and 31 times, respectively. Meanwhile, the part reserved for retail investors was subscribed 8.3 times so far on Day 3.